Search Results

2 items found for "Explicyte"

Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
March 2022 "Explicyte grants Domain Therapeutics exclusivity on data related to GPCR implicated in immunoresistance development of new drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology (IO), and Explicyte
Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
interconnected nodes which learn hierarchical representations of the data, eliminating the need for explicit